Results 61 to 70 of about 3,454 (161)

Mucolytics for bronchiectasis

open access: yes, 2001
First published: 22 January 2001Background Bronchiectasis is predominantly an acquired disease process representing the end stage of a variety of unrelated pulmonary insults.
Josephine M Cranston   +7 more
core   +1 more source

Complete Lung Atelectasis following Caesarean Section in a Case of Imminent Eclampsia: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research
In the early postpartum period, acute life-threatening problems can occur and cause maternal morbidity and mortality. In the present case report, a 19-year-old primipara had undergone caesarean delivery following which she developed breathlessness ...
Rajasri Yaliwal   +4 more
doaj   +1 more source

Maximal Medical Therapy for Chronic Rhinosinusitis: A Survey of Chinese Otolaryngologists

open access: yesEar, Nose & Throat Journal, 2020
The aim of the present study was to evaluate the clinical practice patterns in maximal medical therapy (MMT) before endoscopic sinus surgery for chronic rhinosinusitis (CRS) by Chinese otolaryngologists. An anonymous web-based survey of MMT was performed.
Zhenxiao Huang MD, PhD   +3 more
doaj   +1 more source

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, Volume 56, Issue 10, Page 1162-1176, October 2026.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Use of Antitussive,Mucolytic Agents and Expectorants [PDF]

open access: yes, 2017
Cough associated with acute or chronic respiratory conditions is common in patients of all ages. Current antitussive agents are classified broadly according to their site of action as either central or peripheral, although many antitussives act in both ...
안철민
core   +1 more source

Airway Obstruction Syndrome in Children: the Difficult Questions — the Right Decisions

open access: yesZdorovʹe Rebenka, 2016
The article deals with the questions of pathogenesis, complications and treatment of bronchial obstruction syndrome. Special attention is paid to the treatment of the syndrome of acute and chronic bronchial obstruction.
O.M. Okhotnikova
doaj   +1 more source

Pharmacist’s recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland

open access: yesBMC Family Practice, 2021
Background Common cold is a frequent illness in northern hemisphere between late autumn and early spring. Patients suffering from it frequently turn to pharmacists instead of physicians in order to receive medical advice and treatment.
Malgorzata Pietrusiewicz   +2 more
doaj   +1 more source

Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications

open access: yesFrontiers in Physiology
Chronic airway diseases, including asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis, impose a significant global health burden. A central unifying feature of these diseases is redox imbalance, which is characterized by an excess ...
Mario Cazzola   +6 more
doaj   +1 more source

Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 34, 11 September 2026.
Inhalable immunotherapeutic nanomedicines enable organ‐selective immune modulation by overcoming pulmonary delivery barriers and concentrating therapy within lung tumors. This Review defines how nanomaterial properties govern airway deposition, retention, cellular partitioning, and immune activation across vaccines, checkpoint blockade, STING agonists,
Han Zhang, Wei Tang
wiley   +1 more source

Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2

open access: yes, 2022
The COVID-19 pandemic has been transformed into one of the main worldwide challenges, in recent years. For controlling symptoms that are caused by this disease (e.g., chills or fever, shortness of breath and/or difficulty in breathing, cough, sore throat,
Omid Akhavan, Mahsa Ebrahimi
core   +1 more source

Home - About - Disclaimer - Privacy